Role for cFMS in maintaining alternative macrophage polarization in SIV infection: implications for HIV

Lindsey Gerngross1, Gabrielle Lehmicke2, Aghilas Belkadi3

  • 1Department of Neuroscience, Center for Neurovirology, Temple University School of Medicine, MERB, Room 748, Philadelphia, PA, 19140, USA. lindsey.gerngross@temple.edu.

Abstract

Insights

Macrophage-colony stimulating factor (M-CSF) and IL-34 promote M2 macrophage activation in SIV encephalitis. Targeting cFMS signaling may help eliminate HIV reservoirs in the brain.

Area of Science:

  • Neuroscience
  • Immunology
  • Virology

Background:

  • Macrophage-colony stimulating factor (M-CSF) is implicated in HIV neuropathogenesis by modulating macrophage (MΦ) and microglia activation, increasing susceptibility to infection, and promoting virus production.
  • M-CSF is expressed by perivascular MΦs in SIV encephalitis (SIVE) brain lesions, while IL-34 is found in parenchymal cells.
  • Both M-CSF and IL-34 share the same receptor, cFMS.

Purpose of the Study:

  • To investigate the roles of M-CSF and IL-34 in SIV encephalitis (SIVE) and their effects on macrophage activation.
  • To determine if targeting cFMS signaling could be a therapeutic strategy for HIV infection in the brain.

Main Methods:

  • Immunohistochemistry was used to examine M-CSF, IL-34, and CD163 expression in brain tissue from SIV-infected and non-infected rhesus macaques.
  • Primary rhesus macaque and human monocytes were cultured with M-CSF or IL-34, with or without the cFMS inhibitor GW2580.
  • Flow cytometry was used to analyze the effect of these cytokines on promoting an M2 monocyte/MΦ phenotype.

Main Results:

  • In SIVE brains, M-CSF+ MΦs co-localized with CD163, a marker of M2 activation, while IL-34 did not significantly co-localize with CD163.
  • M-CSF and IL-34 upregulate CD163 expression in primary monocytes, indicating M2 activation.
  • This upregulation of CD163 by M-CSF and IL-34 was attenuated by the cFMS inhibitor GW2580.

Conclusions:

  • Both M-CSF and IL-34 may promote or prolong M2 activation of MΦs and microglia in SIV-infected brains with encephalitis.
  • cFMS signaling represents a potential therapeutic target for eradicating long-lived MΦ reservoirs of HIV infection in the brain and other tissues.